Showing results (11-20 of 68) with videos related to

Sort By:
Pageof 7
Clinical Case Reports|August 21, 2023
An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO-based treatmentRomain Loyaux, Solène Lecolant, Leila Cysique Foilan, et al.
Transplantation|September 29, 2006
Enteral feeding and early outcomes of patients undergoing allogeneic stem cell transplantation following myeloablative conditioningDavid Seguy, Céline Berthon, Jean-Baptiste Micol, et al.
Infection|December 3, 2016
Invasive cutaneous infection due to Scopulariopsis brevicaulis unsuccessfully treated with high-dose micafungin in a neutropenic patientDaniela Gavril, Paul-Louis Woerther, Aicha Ben Lakhdar, et al.
Blood|August 19, 2011
Changes in the dynamics of the excess mortality rate in chronic phase-chronic myeloid leukemia over 1990-2007: a population studySelim Corm, Laurent Roche, Jean-Baptiste Micol, et al.
European Journal of Cancer (Oxford, England : 1990)|November 19, 2013
Identification of methylguanine methyltransferase polymorphisms as genetic markers of individual susceptibility to therapy-related myeloid neoplasmsJulie Dubois, Gabriel Etienne, Audrey Laroche-Clary, et al.
Annals of Hematology|July 11, 2006
Long-term outcome in acquired aplastic anemia treated with an intensified dose schedule of horse antilymphocyte globulin in combination with androgensXavier Leleu, Louis Terriou, Alain Duhamel, et al.
Haematologica|August 4, 2006
An 18-case outbreak of drug-resistant Pseudomonas aeruginosa bacteriemia in hematology patientsJean Baptiste Micol, Stéphane de Botton, Romain Guieze, et al.
Bulletin Du Cancer|October 9, 2025
Therapy related myeloid neoplasm, same but different?Lina El Murr, Khalil Saleh, Florence Pasquier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 21, 2014
Management and treatment results in patients with acute promyelocytic leukaemia (APL) not enrolled in clinical trialsJean Baptiste Micol, Emmanuel Raffoux, Nicolas Boissel, et al.
Blood|August 22, 2014
JAK2 and MPL protein levels determine TPO-induced megakaryocyte proliferation vs differentiationRodolphe Besancenot, Damien Roos-Weil, Carole Tonetti, et al.
Pageof 7